Bolton-Maggs PHB, Pasi KJ (2003) Haemophilias A and B. Lancet 361(9371):1801–1809. https://doi.org/10.1016/S0140-6736(03)13405-8

Article  PubMed  CAS  Google Scholar 

White GC, Rosendaal F, Aledort LM et al (2001) Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 85(3):560.

Mårtensson A, Ivarsson S, Letelier A, Manderstedt E, Halldén C, Ljung R (2016) Origin of mutation in sporadic cases of severe haemophilia A in Sweden. Clin Genet 90(1):63–68. https://doi.org/10.1111/cge.12709

Article  PubMed  CAS  Google Scholar 

Graw J, Brackmann HH, Oldenburg J, Schneppenheim R, Spannagl M, Schwaab R (2005) Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet 6(6):488–501. https://doi.org/10.1038/nrg1617

Article  PubMed  CAS  Google Scholar 

Lu Y, Xin Y, Dai J et al (2018) Spectrum and origin of mutations in sporadic cases of haemophilia A in China. Haemophilia 24(2):291–298. https://doi.org/10.1111/hae.13402

Article  PubMed  CAS  Google Scholar 

Guo Z, Yang L, Qin X, Liu X, Zhang Y (2018) Spectrum of molecular defects in 216 Chinese families with hemophilia A: identification of noninversion mutation hot spots and 42 novel mutations. Clin Appl Thromb Hemost 24(1):70–78. https://doi.org/10.1177/1076029616687848

Article  PubMed  CAS  Google Scholar 

Bagnall RD, Waseem N, Green PM, Giannelli F (2002) Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 99(1):168–174. https://doi.org/10.1182/blood.v99.1.168

Article  PubMed  CAS  Google Scholar 

Oldenburg J, Rost S, El-Maarri O et al (2000) De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism. Blood 96(8):2905–2906

Article  PubMed  CAS  Google Scholar 

Collins PW, Palmer BP, Chalmers EA et al (2014) Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000–2011. Blood 124(23):3389–3397. https://doi.org/10.1182/blood-2014-07-580498

Article  PubMed  PubMed Central  CAS  Google Scholar 

Peyvandi F, Mannucci PM, Garagiola I et al (2016) A randomized trial of factor VIII and neutralizing antibodies in hemophilia A. N Engl J Med 374(21):2054–2064. https://doi.org/10.1056/NEJMoa1516437

Article  PubMed  CAS  Google Scholar 

Nathwani AC (2022) Gene therapy for hemophilia. Hematology Am Soc Hematol Educ Program 2022(1):569–578. https://doi.org/10.1182/hematology.2022000388

Article  PubMed  PubMed Central  Google Scholar 

Kumar P, Husain N, Soni P, Faridi NJ, Goel SK (2015) New protocol for detection of intron 22 inversion mutation from cases with hemophilia A. Clin Appl Thromb Hemost 21(3):255–259. https://doi.org/10.1177/1076029613498817

Article  PubMed  CAS  Google Scholar 

Lin SY, Su YN, Hung CC et al (2008) Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM. BMC Med Genet 9:53. https://doi.org/10.1186/1471-2350-9-53

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abou-Elew H, Ahmed H, Raslan H et al (2011) Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients. Ann Hematol 90(5):579–584. https://doi.org/10.1007/s00277-010-1115-x

Article  PubMed  Google Scholar 

Pan TY, Wang CC, Shih CJ, Wu HF, Chiou SS, Wu SM (2014) Genotyping of intron 22 inversion of factor VIII gene for diagnosis of hemophilia A by inverse-shifting polymerase chain reaction and capillary electrophoresis. Anal Bioanal Chem 406(22):5447–5454. https://doi.org/10.1007/s00216-014-7969-3

Article  PubMed  CAS  Google Scholar 

He ZH, Chen SF, Chen J, Jiang WY (2012) A modified I-PCR to detect the factor VIII Inv22 for genetic diagnosis and prenatal diagnosis in haemophilia A. Haemophilia 18(3):452–456. https://doi.org/10.1111/j.1365-2516.2011.02670.x

Article  PubMed  CAS  Google Scholar 

Kumar P, Husain N, Soni P, Faridi NJ, Goel SK (2015) New protocol for detection of intron 22 inversion mutation from cases with hemophilia A. Clin Appl Thromb Hemost 21(3):255–259. https://doi.org/10.1177/1076029613498817

Article  PubMed  CAS  Google Scholar 

Johnsen JM, Fletcher SN, Huston H et al (2017) Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life. Our Future initiative Blood Adv 1(13):824–834. https://doi.org/10.1182/bloodadvances.2016002923

Article  PubMed  CAS  Google Scholar 

Ling X, Pan L, Li L et al (2024) Detection of hemophilia A genetic variants using third-generation long-read sequencing. Clin Chim Acta 562:119884. https://doi.org/10.1016/j.cca.2024.119884

Article  PubMed  CAS  Google Scholar 

Shi M, Ma Y, Peng X et al (2024) Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing-based analysis for hemophilia: experience from a hemophilia treatment center in China. J Thromb Haemost 22(12):3431–3447. https://doi.org/10.1016/j.jtha.2024.08.013

Article  PubMed  CAS  Google Scholar 

Schmeer M, Schleef M, Shankar R, Kobelt D, Walther W (2022) Capillary gel electrophoresis (CGE) for quality control of plasmid DNA in gene therapy: quality control of 20 years stored GMP-grade plasmid DNA. Methods Mol Biol 2521:317–328. https://doi.org/10.1007/978-1-0716-2441-8_17

Article  PubMed  CAS  Google Scholar 

Wang W, Gao T, Luo J et al (2023) Size distribution analysis of residual host cell DNA fragments in lentivirus by CGE-LIF. Electrophoresis 44(3–4):462–471. https://doi.org/10.1002/elps.202200218

Article  PubMed  CAS  Google Scholar